Stefan Grass
Nessuna posizione attualmente
Storia della carriera di Stefan Grass
Precedenti posizioni note di Stefan Grass
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
CSL Behring AB
 CSL Behring AB Pharmaceuticals: MajorHealth Technology CSL Behring AB develops, manufactures, and markets protein-based therapies in the bleeding disorders, critical care, immunoglobulins, and pulmonary areas. It offers therapies such as plasma-derived and recombinant coagulation factors, immunoglobulins for the treatment of primary immune deficiency, alpha1-proteinase inhibitor for chronic A1-PI augmentation therapy, and C1-INH concentrate. The company was founded in 1904 and is headquartered in Danderyd, Sweden. | Corporate Officer/Principal | - | - |
| BACTIGUARD HOLDING AB | Direttore Tecnico/Scientifico/R&S | 31/10/2019 | - |
Formazione di Stefan Grass
| Karolinska Institutet | Doctorate Degree |
Statistiche
Distribuzione geografica
| Svezia | 4 |
Posizioni
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BACTIGUARD HOLDING AB | Health Technology |
| Aziende private | 1 |
|---|---|
CSL Behring AB
CSL Behring AB Pharmaceuticals: MajorHealth Technology CSL Behring AB develops, manufactures, and markets protein-based therapies in the bleeding disorders, critical care, immunoglobulins, and pulmonary areas. It offers therapies such as plasma-derived and recombinant coagulation factors, immunoglobulins for the treatment of primary immune deficiency, alpha1-proteinase inhibitor for chronic A1-PI augmentation therapy, and C1-INH concentrate. The company was founded in 1904 and is headquartered in Danderyd, Sweden. | Health Technology |
- Borsa valori
- Insiders
- Stefan Grass
- Esperienza
